| Metric | FY 2021 | Prior Q | FY 2020 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $656M | — | $680M | — | -3.6% |
| Op. Income | $248M | — | $209M | — | 18.4% |
| Gross Margin | 99.6% | — | 87.7% | — | 11.9pp |
| Net Margin | 29.3% | — | 23.7% | — | 5.6pp |
| EPS (Diluted) | $3.11 | — | $2.53 | — | 22.9% |
| Free Cash Flow | $272M | — | $238M | — | 14.2% |
| Item | Amount |
|---|---|
| REVENUE | $656M |
| Cost of Revenue | $3M |
| GROSS PROFIT | $653M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $227M |
| SG&A Expenses | $227M |
| Other Expenses | $178M |
| Operating Expenses | $406M |
| Cost & Expenses | $408M |
| OPERATING INCOME | $248M |
| Interest Income | $507M |
| Interest Expense | $17M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $248M |
| Income Tax Expense | $56M |
| Net Income from Continuing Ops | $192M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $192M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $192M |
| D&A | $44M |
| EBIT | $248M |
| EBITDA | $292M |
| EPS | $3 |
| EPS Diluted | $3 |
| Item | Amount |
|---|---|
| REVENUE | $656M |
| Cost of Revenue | $3M |
| GROSS PROFIT | $653M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $227M |
| SG&A Expenses | $227M |
| Other Expenses | $178M |
| Operating Expenses | $406M |
| Cost & Expenses | $408M |
| OPERATING INCOME | $248M |
| Interest Income | $507M |
| Interest Expense | $17M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $248M |
| Income Tax Expense | $56M |
| Net Income from Continuing Ops | $192M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $192M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $192M |
| D&A | $44M |
| EBIT | $248M |
| EBITDA | $292M |
| EPS | $3 |
| EPS Diluted | $3 |
| Item | Amount |
|---|---|
| Net Income | $192M |
| Depreciation & Amortization | $44M |
| Stock-Based Compensation | $9M |
| Deferred Income Tax | $5M |
| Other Non-Cash Items | $48M |
| Change in Working Capital | -$16M |
| OPERATING CASH FLOW | $282M |
| Capital Expenditure | -$10M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$4.0B |
| Sales/Maturities of Investments | $1.4B |
| Other Investing Activities | $469M |
| NET CASH FROM INVESTING | -$2.1B |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | -$5M |
| Common Dividends Paid | -$102M |
| Other Financing Activities | $2.0B |
| NET CASH FROM FINANCING | $1.9B |
| FREE CASH FLOW | $272M |
| Net Change in Cash | $68M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $2.3B |
| Short-Term Investments | $4.8B |
| Net Receivables | $47M |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $7.2B |
| PP&E (Net) | $300M |
| Goodwill | $622M |
| Intangible Assets | $70M |
| Long-Term Investments | $10.9B |
| Tax Assets | $0 |
| Other Non-Current Assets | $542M |
| TOTAL NON-CURRENT ASSETS | $12.5B |
| TOTAL ASSETS | $19.7B |
| Account Payables | $152M |
| Short-Term Debt | $1.1B |
| Deferred Revenue | $0 |
| Other Current Liabilities | $16.3B |
| TOTAL CURRENT LIABILITIES | $17.5B |
| Long-Term Debt | $198M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $9M |
| Other Non-Current Liabilities | $4M |
| TOTAL NON-CURRENT LIABILITIES | $213M |
| TOTAL LIABILITIES | $17.7B |
| Common Stock | $945M |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $1.1B |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$11M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $2.0B |
| Minority Interest | $0 |
| TOTAL EQUITY | $2.0B |
| TOTAL LIABILITIES & EQUITY | $19.7B |
| Total Debt | $1.3B |
| Net Debt | -$1.1B |